ArticleOncogene2022

Correction: Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor.

Yan Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.